SynthesisCancer immunology, immunotherapy : CII2022

EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis.

Huimin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.